Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution (Q58168549)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution	article

Statements

scholarly article

0 references

Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution (English)

0 references

0 references

chronic pancreatitis

1 reference

based on heuristic

inferred from title

object named as

Sten Madsbad

6

0 references

Jens Juul Holst

object named as

Jens J. Holst

7

0 references

2

object named as

Tina Vilsbøll

0 references

1

object named as

Filip K. Knop

0 references

5

object named as

Aage Vølund

0 references

Patricia M V Højberg

4

object named as

Patricia V. Højberg

0 references

author name string

Steen Larsen

3

0 references

Thure Krarup

8

0 references

publication date

January 2007

0 references

American Journal of Physiology - Endocrinology and Metabolism

0 references

292

0 references

1

0 references

E324-E330

0 references

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Pancreatography in chronic pancreatitis: international definitions

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Pancreatic beta-cell function and glucose metabolism in human segmental pancreas and kidney transplantation.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Nutrient, neural and endocrine control of glucagon-like peptide secretion

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

On the physiology of GIP and GLP-1.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Measuring pre-hepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Pancreatic Enzyme Supplementation Therapy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Validation of methods for measurement of insulin secretion in humans in vivo.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Diminished Immunoreactive Gastric Inhibitory Polypeptide Response to a Meal in Newly Diagnosed Type I (Insulin-Dependent) Diabetics*

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00059.2006

21 January 2018

Identifiers

10.1152/AJPENDO.00059.2006

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58168549&oldid=1820038270"